Kymera Therapeutics
Price & Volume
Stats
See more52W Range | $56.75-$133.87 |
Market Cap | $10.8B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $102.2M |
Revenue Growth (YoY) | 466.4% |
Gross Profit (12 Mos) | -$327.7M |
Diluted EPS | -$3.64 |
News
See moreYahoo Finance • 6 days ago
Kymera Therapeutics GAAP EPS of -$1.32 misses by $0.05
Yahoo Finance • 16 days ago
Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast
Yahoo Finance • last month
13 High-Conviction & Catalyst-Driven Long Ideas for 4Q 2026
Yahoo Finance • 2 months ago
Kymera's KT-621 Has 'Oral Dupixent' Potential, but Valuation Limits Upside, RBC Says
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 285 |